NPPA fixes retail prices of 37 formulations, including Sitagliptin- Metformin combinations

Published On 2022-09-17 12:30 GMT | Update On 2023-10-17 10:57 GMT

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 37 formulations including those used to treat a wide variety of bacterial infections, used in the treatment of Angina, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal reflux disease under Drugs (Prices Control) Order, 2013.This price fixation list...

This price fixation list includes diabetes medication Dapagliflozin & Metformin Hydrochloride Extended-Release Tablets manufactured by Synokem Pharma, Hetero Healthcare; Sitagliptin and Metformin Hydrochloride Tablets manufactured by Hetero Labs, Hetero Healthcare.

The list further includes Aspirin Gastroresistant and Atorvastatin Capsules manufactured by Tristar Formulations, Mankind Pharma; Metoprolol Succinate (As Extended Release), Cilnidipine & Telmisartan Tablets manufactured by Pure and Cure Healthcare, Cipla; Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension manufactured by Akums Drugs & Pharma, Cadila Pharma; Paracetamol Infusion manufactured by R K Laboratories (P) Ltd., Mankind Prime Labs.

This price fixation is followed by the decisions made by the National Pharmaceutical Pricing Authority at 101st Authority meeting dated 07.09.2022.

This came in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Dapagliflozin & Metformin Hydrochloride Extended- Release Tablets	Each film coated tablet contains: Metformin Hydrochloride 500mg (as extended-release form) Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 10mg	1 Tablet	M/s Synokem Pharmaceutical Ltd. / M/s Hetero Healthcare Ltd.	9.27
2.	Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension	Each 5ml Contains: Sodium Alginate IP 250mg, Sodium Bicarbonate IP 133.5mg, Calcium Carbonate IP 80mg	1 ml	M/s Akums Drugs & Pharmaceuticals Ltd. /M/s Cadila Pharmaceuticals Ltd.	0.88
3.	Cilnidipine & Metoprolol Succinate (ER) Tablets	Each film coated bilayered tablet contains: Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (as extended- release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Troikaa Pharmaceuticals Ltd.	7.22
4.	Cilnidipine & Metoprolol Succinate (ER) Tablets	Each film coated bilayered tablet contains: Cilnidipine IP 10mg Metoprolol Succinate IP eq. to Metoprolol Tartrate 50mg (as extended-release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Troikaa Pharmaceuticals Ltd.	9.25
5.	Paracetamol Infusion IP (1%w/v)	Each 100ml contains: Paracetamol IP 1000mg water for Injection IP q.s.	1 ml	M/s R. K. Laboratories (P) Ltd. / M/s Mankind Prime Labs Pvt. Ltd.	3.02
6.	Telmisartan & Metoprolol Succinate (ER) Tablets	Each film coated tablets contains: Telmisartan IP 40mg Metoprolol Succinate IP 25mg (As Extended-release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Indchemie Health Specialities Pvt. Ltd.	12.01
7.	Telmisartan, Amlodipine & Hydrochlorothia zide Tablets	Each film coated tablets contains: Telmisartan IP 80mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.5mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	15.15
8.	Telmisartan & Metoprolol Succinate (ER) Tablets	Each film coated tablets contains: Telmisartan IP 40mg Metoprolol Succinate IP 50mg (As Extended-release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Indchemie Health Specialities Pvt. Ltd.	14.03
9.	Etoricoxib and Paracetamol Tablets	Each Film Coated tablet contains: Etoricoxib IP 60 mg Paracetamol IP 325 mg	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Wockhardt Limited	8.03
10.	Amoxycillin & Potassium Clavulanate Oral Suspension IP	Each 5ml of constituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg	1 ml	M/s Malik Lifesciences Pvt. Ltd. / M/s Mankind Pharma Ltd.	3.24
11.	Aspirin Gastro- resistant and Atorvastatin Capsules	Each hard gelatin capsule contains: Aspirin IP (as Gastro-resistant Tablet IP) 75mg Atorvastatin Calcium IP eq. To Atorvastatin IP 20mg	1 Capsule	M/s Tristar Formulations Pvt. Ltd. / M/s Mankind Pharma Limited	2.93
12.	Metoprolol Succinate (As Extended Release), Cilnidipine & Telmisartan Tablets	Each film coated tablet contains: Metoprolol Succinate IP 23.75mg eq. to Metoprolol tartrate 25mg (As Extended Release) Cilnidipine IP 10mg Telmisartan IP 40mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	10.04
13.	Metoprolol tartrate and Ivabradine Tablets	Each film coated tablet contains: Metoprolol tartrate IP 50mg Ivabradine Hydrochloride eq. to Ivabradine 5mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	16.70
14.	Beclomethasone Dipropionate, Neomycin Sulphate & Clotrimazole Cream	Composition: Beclomethasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP eq. to Neomycin 0.50% w/w Clotrimazole IP 1.00% w/w	1 gm	M/s Curetech Skincare / M/s Eris Healthcare Pvt. Ltd.	5.65
15.	Metoprolol tartrate and Ivabradine Tablets	Each film coated tablet contains: Metoprolol tartrate IP 25mg Ivabradine Hydrochloride eq. to Ivabradine 5mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	14.56
16.	Thiocolchicosid, Aceclofenac and Paracetamol Tablets	Each film coated tablet contains: Thiocolchicoside IP 8mg Aceclofenac IP 100mg Paracetamol IP 325mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	18.75
17.	Thiocolchicosid, Aceclofenac and Paracetamol Tablets	Each film coated tablet contains: Thiocolchicoside IP 4mg Aceclofenac IP 100mg Paracetamol IP 325mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	16.07
18.	Tranexamic Acid & Mefenamic Acid tablets	Each film coated tablet contains: Tranexamic Acid IP 500mg Mefenamic Acid IP 250mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Micro Labs Ltd.	26.79
19.	Telmisartan, Chlorthalidone & Metoprolol (ER) Tablets	Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.5mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (as extended release)	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Mankind Pharma Ltd.	13.40
20.	Metoprolol Succinate (As Extended Release), Cilnidipine & Telmisartan Tablets	Each film coated tablet contains: Metoprolol Succinate IP 47.50mg eq. to Metoprolol tartrate 50mg (As Extended Release) Cilnidipine IP 10mg Telmisartan IP 40mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd.	12.46
21.	Povidone-Iodine Ointment USP	Composition: Povidone-Iodine IP 5%w/w (Available Iodine 0.5%w/w)	1 gm	M/s Nanz Med Science Pharma Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	1.66
22.	Esomeprazole and Domperidone Sustained Release capsule	Each Hard Gelatin Capsule Contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (as enteric coated pellets) Domperidone IP 30mg (as sustained release pellets)	1 Capsule	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd.	11.32
23.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aprica Healthcare Limited	18.34
24.	Sitagliptin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (As Sustained release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aprica Healthcare Limited	18.67
25.	Sitagliptin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (As Sustained release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aprica Healthcare Limited	20.06
26.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aprica Healthcare Limited	20.02
27.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (as Extended-Release Form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	18.67
28.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each bilayered film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended-Release Form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	20.17
29.	Sitagliptin and metformin Hydrochloride (ER) Tablets	Each bilayered film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended-Release Form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	21.56
30.	Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (as Extended-Release Form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	20.06
31.	Sitagliptin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (As Sustained release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	20.17
32.	Sitagliptin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (As Sustained release)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	21.56
33.	Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Hetero Labs Ltd. / M/s Hetero Healthcare Ltd.	14.28
34.	Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Hetero Labs Ltd. / M/s Hetero Healthcare Ltd.	15.17
35.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Psychotropics India Limited	17.87
36.	Sitagliptin Phosphate and Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Psychotropics India Limited	16.37

In the same meeting the authority has also fixed the retail price of Sun Pharma's Rosuvastatin plus Clopidogrel Capsule.

Sl.

No.

Name of the scheduled Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Rosuvastatin + Clopidogrel Capsule

Each hard gelatine capsules contain: Rosuvastatin 10mg, Clopidogrel 75mg

1 Capsule

M/s Sun Pharma Industries Ltd.

13.02

Note:

(a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

For official notices, check out the below mentioned links:

https://medicaldialogues.in/pdf_upload/wpaenglish-222096.pdf

https://medicaldialogues.in/pdf_upload/retailenglish-222097.pdf

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

NPPA fixes retail prices of 37 formulations, including Sitagliptin- Metformin combinations

Similar News